![](https://indagoresearch.org/wp-content/uploads/2024/07/LAA2_Diabetes_picture-500x480.jpg)
LAA2 is a new clinical research study from Eli Lilly and Company. It is testing if an investigational medicine (a medicine being studied) may help treat people with obesity or overweight and type 2 diabetes.
LAA2 is a new clinical research study from Eli Lilly and Company. It is testing if an investigational medicine (a medicine being studied) may help treat people with obesity or overweight and type 2 diabetes.
Your participation in the study will help to determine whether an investigational vaccine helps to provide protection against RSV in different populations.